Congress trades

QuidelOrtho Corporation (QDEL)

NASDAQ · Healthcare · 9 congress trades · last filed 3 years ago

9
Congress disclosures shown
32d
Median delay on the congress disclosures
of the 45 day limit
2/7
Purchases and sales in the disclosures shown

About QuidelOrtho Corporation

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Specialties
Chief executive
Brian J. Blaser
Employees
6,500
Listed since
Feb 1, 1991
Market value
$861.9M
Price to earnings
-
Earnings per share
-$15.35
Dividend yield
-

www.quidelortho.com

Earnings

6 reported quarters · next on Nov 4, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 6, 2026$0.13-$0.05$630.9M$618.7MEPS beatRevenue beat
Q1 FY2026reported May 5, 2026-$0.04$0.37$619.8M$665.2MEPS missRevenue miss
Q4 FY2025reported Feb 11, 2026$0.46$0.43$723.6M$700.7MEPS beatRevenue beat
Q3 FY2025reported Nov 5, 2025$0.80$0.51$699.9M$669.3MEPS beatRevenue beat
Q2 FY2025reported Aug 5, 2025$0.12$0.00$613.9M$611.1MEPS beatRevenue in line
Q1 FY2025reported May 7, 2025$0.74$0.58$692.8M$689.6MEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 27, 2026
ExecutiveSalaryStock awardsOtherTotal
Brian J. BlaserPresident and CEO$1.0M$9.0M$1.3M$11.3M
Joseph M. BuskyCFO$680K$2.7M$2.0M$5.4M
Philip D. McLellanCOO$515K$639K$868K$2.0M
Jonathan P. SiegristEVP of R&D and CTO$575K$320K$896K$1.8M

The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$196.2M11,202,523+7.2%16.40%
FMR LLC$129.0M7,363,696+11.7%10.78%
Newtyn Management, LLC$116.0M6,625,000+45.3%9.70%
Vanguard Portfolio Management LLC$72.4M4,135,464+2.6%6.05%
Neuberger Berman Group LLC$62.1M3,534,619+131.0%5.18%
Invesco Ltd.$60.8M3,473,432+11.4%5.09%
American Century Companies Inc$57.9M3,307,079+15.8%4.84%
Rubric Capital Management LP$57.9M3,306,2810.0%4.84%
Vanguard Capital Management LLC$53.8M3,070,054+0.6%4.50%
State Street Corp$52.2M2,978,639+6.9%4.36%
Paradigm Capital Management Inc/Ny$44.2M2,521,700+65.3%3.69%
Private Management Group Inc$36.3M2,070,391+49.5%3.03%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next QDEL filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in QDEL

9 disclosures of 9 on record · median 32d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Daniel S. GoldmanStockSale$1,001 - $15,000-85.5%S&P +71.0% · vs S&P 500 -156.6%Jul 12, 2023Aug 13, 202332d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-93.6%S&P +113.0% · vs S&P 500 -206.7%Nov 13, 2020Dec 15, 202032d
Josh GottheimerJointStockSale$1,001 - $15,000-94.1%S&P +113.9% · vs S&P 500 -208.0%Nov 11, 2020Dec 9, 202028d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-95.3%S&P +135.5% · vs S&P 500 -230.8%Jul 30, 2020Aug 19, 202020d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-94.6%S&P +142.4% · vs S&P 500 -237.0%Jul 13, 2020Aug 19, 202037d
Josh GottheimerJointStockSale$1,001 - $15,000-94.7%S&P +141.4% · vs S&P 500 -236.0%Jul 8, 2020Aug 10, 202033d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-93.0%S&P +158.7% · vs S&P 500 -251.7%May 21, 2020Jun 16, 202026d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000-84.4%S&P +165.7% · vs S&P 500 -250.0%Mar 10, 2020Apr 16, 202037d
Josh GottheimerJointStockPurchase$1,001 - $15,000-84.3%S&P +146.9% · vs S&P 500 -231.2%Mar 2, 2020Apr 11, 202040d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Questions

Which members of Congress have traded QDEL?

Daniel S. Goldman, Gilbert Ray Cisneros, Jr., Josh Gottheimer disclosed QDEL transactions in the filings shown here.

How quickly are QDEL trades disclosed?

Congressional disclosures took a median of 32 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track